Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8714639 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 11 Pages |
Abstract
Antibiotic allergy labeling is highly prevalent and negatively impacts patient outcomes and antibiotic appropriateness. Reducing the prevalence and burden of antibiotic allergies requires the engagement of key stakeholders such as allergists, immunologists, pharmacists, and infectious diseases physicians. To help address this burden of antibiotic allergy overlabeling, we review 3 key antibiotic allergy domains: (1) antibiotic allergy classification, (2) antibiotic cross-reactivity, and (3) multidisciplinary collaboration. We review the available evidence and research gaps of currently used adverse drug reaction classification systems, antibiotic allergy cross-reactivity, and current and future models of antibiotic allergy care.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jason A. MD, Cosby A. MD, M. Lindsay MD, Karen BPharm, Monica A. MD, Karin A. MD, Elizabeth J. MD,